Compare CCLD & ATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CCLD | ATRA |
|---|---|---|
| Founded | 1999 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 98.6M | 94.2M |
| IPO Year | 2013 | 2014 |
| Metric | CCLD | ATRA |
|---|---|---|
| Price | $1.73 | $8.59 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 3 |
| Target Price | $7.33 | ★ $13.67 |
| AVG Volume (30 Days) | ★ 218.7K | 20.3K |
| Earning Date | 11-05-2026 | 11-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 135.71 | 122.52 |
| EPS | ★ N/A | N/A |
| Revenue | $120,499,000.00 | ★ $120,772,000.00 |
| Revenue This Year | $8.14 | N/A |
| Revenue Next Year | $9.63 | $1,334.59 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 8.72 | N/A |
| 52 Week Low | $1.69 | $3.92 |
| 52 Week High | $3.81 | $19.15 |
| Indicator | CCLD | ATRA |
|---|---|---|
| Relative Strength Index (RSI) | 38.76 | 40.53 |
| Support Level | N/A | $7.72 |
| Resistance Level | $2.42 | $9.93 |
| Average True Range (ATR) | 0.09 | 0.57 |
| MACD | 0.01 | -0.11 |
| Stochastic Oscillator | 28.57 | 21.26 |
CareCloud Inc delivers flexible, tech-enabled solutions for healthcare providers of all sizes and multi-specialties across the U.S. It is a healthcare technology company offering cloud-based solutions that simplify clinical, administrative, and financial workflows for medical practices of all sizes. Its comprehensive suite includes Electronic Health Records (EHRs), Practice Management, Revenue Cycle Management (RCM), Medical Billing, Telehealth, and Patient Experience solutions. The group helps practices increase efficiency, improve patient care, and drive sustainable growth-all while ensuring HIPAA compliance and seamless integration. The operating segments of the group are Healthcare IT, which is the key revenue-generating segment, and Medical Practice Management.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA3431, and ATA3219.